share_log

Laidlaw & Co. Initiates Coverage On SILO Pharma With Buy Rating, Announces Price Target of $10

Benzinga ·  Aug 28, 2023 04:51

Laidlaw & Co. analyst Yale Jen initiates coverage on SILO Pharma (NASDAQ:SILO) with a Buy rating and announces Price Target of $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment